rs174546, FADS1;FADS2

N. diseases: 7
Source: GWASCAT ×
Disease N. SNPs d DSI v DPI v Chr Position Consequence Alleles Class AFEXOME AFGENOME Score vda EI vda N. PMIDs First Ref. Last Ref.
High density lipoprotein measurement
CUI: C0392885
Disease: High density lipoprotein measurement
951 0.807 0.200 11 61802358 3 prime UTR variant C/T snv 0.28 0.800 1.000 7 2010 2019
Low density lipoprotein cholesterol measurement
CUI: C0202117
Disease: Low density lipoprotein cholesterol measurement
731 0.807 0.200 11 61802358 3 prime UTR variant C/T snv 0.28 0.800 1.000 6 2009 2019
Triglycerides measurement
CUI: C0202236
Disease: Triglycerides measurement
837 0.807 0.200 11 61802358 3 prime UTR variant C/T snv 0.28 0.800 1.000 6 2008 2019
Serum total cholesterol measurement
CUI: C1445957
Disease: Serum total cholesterol measurement
766 0.807 0.200 11 61802358 3 prime UTR variant C/T snv 0.28 0.800 1.000 4 2010 2019
Metabolic Syndrome X
CUI: C0524620
Disease: Metabolic Syndrome X
124 0.807 0.200 11 61802358 3 prime UTR variant C/T snv 0.28 0.800 1.000 1 2010 2010
C-reactive protein measurement
CUI: C0201657
Disease: C-reactive protein measurement
250 0.807 0.200 11 61802358 3 prime UTR variant C/T snv 0.28 0.700 1.000 1 2016 2016
QT interval feature (observable entity)
CUI: C0429028
Disease: QT interval feature (observable entity)
177 0.807 0.200 11 61802358 3 prime UTR variant C/T snv 0.28 0.700 1.000 1 2019 2019